Abstract

To determine whether inhibition of either the ribosomal p70 S6 kinase or eukaryotic initiation factor (eIF) 4E pathways downstream of the mammalian target of rapamycin, mTOR, contributes to rapamycin-induced growth arrest, clones of Rh30 rhabdomyosarcoma cells were selected for rapamycin resistance. Expression of c-Myc and anchorage-independent growth were enhanced in resistant cells. Resistance was unstable in each of three clones characterized. In resistant cells, as compared with parental cells, approximately 10-fold less 4E-binding protein (4E-BP) was bound to eIF4E, and total cellular 4E-BP was markedly reduced. Levels of eIF4E were unchanged. Steady-state levels of 4E-BP transcript remained unaltered, but the rate of 4E-BP synthesis was reduced in resistant cells. In cells that reverted to rapamycin sensitivity, levels of total 4E-BP returned to those of parental cells. Compared with parental cells, resistant clones had either similar or lower levels and activity of ribosomal p70 S6 kinase, but c-Myc levels were elevated in both resistant and revertant clones. Several colon carcinoma cell lines with intrinsic rapamycin resistance were found to have low 4E-BP:eIF4E ratios. In stable clones of HCT8 carcinoma engineered to overexpress 4E-BP, rapamycin sensitivity increased markedly (>1000-fold) as 4E-BP expression increased. These results suggest that the 4E-BP:eIF4E ratio is an important determinant of rapamycin resistance and controls certain aspects of the malignant phenotype.

Highlights

  • Rapamycin is a macrocyclic lactone antibiotic that potently inhibits the activation of T cells and the growth of many malignant cells in culture [1,2,3,4,5]

  • These results suggest that the 4E-binding protein (4E-BP):eIF4E ratio is an important determinant of rapamycin resistance and controls certain aspects of the malignant phenotype

  • The Rate of 4E-BP Synthesis Is Reduced in Resistant Cells—We investigated whether steady-state levels of 4E-BP were reduced in resistant clones because of decreased synthesis or because of increased degradation

Read more

Summary

EXPERIMENTAL PROCEDURES

Cell Lines—The rhabdomyosarcoma cell lines Rh30 and Rh18 [33, 37] and the G2 glioblastoma cell line [37] were established from pediatric tumors. Samples were incubated (37 °C, 5% CO2) for up to 4 h, washed twice with 10 ml of cold PBS, and lysed at 4 °C for 1 h in 1 ml of cell lysis buffer (Cell Signaling, Beverly, MA) containing protease inhibitors. Western Analysis of 4E-BP1—Cultured cells at a logarithmic phase of growth were briefly washed with cold PBS, and samples containing 1.5 ϫ 106 cells were lysed on ice in 75 ␮l of lysis buffer containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM ␤-glycerophosphate, 1 mM Na3VO4, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, and 1 tablet of protease inhibitor mixture (Roche CompleteTM Mini). Colonies were enumerated by using an AlphaImager 2000TM (Alpha Innotech Corp.)

RESULTS
Colony count
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call